The likelihood of adverse events, such as admission to the intensive care unit (ICU), the need for mechanical breathing assistance, or hospital death, was lowest in people who had taken SGLT2 inhibitors for at least 14 days before testing positive for COVID-19. According to a recent review published in
People with type 1 diabetes who utilized a CGM device experienced a better reduction in A1C by an average of 0.26% after a year. Continuous glucose monitoring involves wearing a sensor under your skin (or having one implanted under your skin) that communicates glucose readings to a suitable device
Among the modifications to the annual American Diabetes Association (ADA) Standards of Care in Diabetes—2023 are new, more aggressive blood pressure and cholesterol targets. The emphasis of this year’s adjustments, which include modifications to the advice on weight loss, high blood pressure, cholesterol, and other topics, is on how
GLP-1 receptor agonists are a relatively new class of diabetes medications that imitate a hormone that is missing in type 2 diabetics. According to a recent study published in the journal Diabetes Care, taking a GLP-1 receptor agonist, a class of glucose-lowering medications for type 2 diabetes, may increase
A recent study that was just published in the journal JAMA Neurology suggests that a person’s midlife intake of ultra-processed meals is associated with the likelihood of cognitive deterioration. Numerous food and lifestyle choices have been related to an increased risk of dementia or cognitive decline (advanced cognitive impairment).
